Essity AB (ESSITY-B.ST) is a leading global hygiene and health company with brands like TENA, Tork, and Libero. The company is benefiting from a restructuring program that is driving margin expansion, while its focus on premium products and emerging markets supports revenue growth. With a strong balance sheet and a dividend yield of ~3%, Essity offers a compelling risk-reward for consumer compounder investors.
Thesis
Essity is executing a comprehensive cost-saving and efficiency program that is expected to deliver SEK 2.5 billion in annual savings by 2025. Combined with a shift towards higher-margin professional hygiene and health products, we anticipate EBIT margin expansion from ~11% in 2024 to 13%+ by 2026. The company also benefits from secular trends in hygiene awareness and aging populations, driving demand for incontinence products.
12-Month Catalysts
- Completion of restructuring program leading to margin improvement
- Launch of new premium products in emerging markets
- Potential divestiture of non-core assets to unlock value
Key Risks
- Raw material cost inflation (pulp, energy) could pressure margins
- Currency headwinds from emerging market exposure
Valuation
Essity trades at ~15x forward P/E, a discount to peers like Kimberly-Clark (~18x) and Procter & Gamble (~22x). With expected EPS growth of 10-12% annually, the PEG ratio is below 1.5, indicating undervaluation.
Balance Sheet
Net debt/EBITDA is ~1.5x, with strong free cash flow generation. The company has investment-grade credit ratings and ample liquidity.
Disclaimer: This is not financial advice. Investing involves risk, including loss of principal. Do your own research.